STAT+: Pharmalittle: FDA Finds Problems At Novo’s Main U.S. Factory; Polarizing ALS Drug Heads For FDA Scrutiny
FDA inspectors issued a report detailing quality control lapses at Novo Nordisk's main factory in North America as early as May last year.